A mutated superantigen SEA D227A fusion diabody specific to MUC1 and CD3 in targeted cancer immunotherapy for bile duct carcinoma.
Takemura S, Kudo T, Asano R, Suzuki M, Tsumoto K, Sakurai N, Katayose Y, Kodama H, Yoshida H, Ebara S, Saeki H, Imai K, Matsuno S, Kumagai I.
Takemura S, et al. Among authors: tsumoto k.
Cancer Immunol Immunother. 2002 Mar;51(1):33-44. doi: 10.1007/s00262-001-0245-3. Epub 2002 Jan 11.
Cancer Immunol Immunother. 2002.
PMID: 11845258
Free PMC article.